CML (Chronic Phase) Panel, FISH+KT

CML (Chronic Phase) Panel, FISH + KT

The CML (Chronic Phase) Panel, FISH + Karyotyping (KT) is a specialized diagnostic test used to detect chromosomal abnormalities associated with Chronic Myeloid Leukemia (CML). It combines Fluorescence In Situ Hybridization (FISH) and Conventional Karyotyping (KT) to identify the BCR::ABL1 (Philadelphia chromosome) and other chromosomal changes, aiding in diagnosis, prognosis, and treatment planning.

Test Details

• Sample Type: Bone Marrow / Peripheral Blood (as recommended)
• Method: Fluorescence In Situ Hybridization (FISH) + Conventional Karyotyping (KT)
• Condition Evaluated: Chronic Myeloid Leukemia (CML) – Chronic Phase

Why is this Test Done?

• Detects the Philadelphia chromosome (BCR::ABL1 fusion)
• Confirms the diagnosis of Chronic Myeloid Leukemia
• Identifies additional chromosomal abnormalities
• Assists in risk stratification and prognosis
• Supports treatment planning and disease monitoring

Who Should Get Tested?

• Individuals with suspected CML based on blood counts or clinical findings
• Patients with confirmed CML requiring cytogenetic evaluation
• Individuals undergoing baseline assessment before targeted therapy
• Patients requiring monitoring for disease progression or treatment response

Preparation

• No special preparation is generally required.
• Follow your healthcare provider's instructions regarding sample collection.

Reporting Time

Approximately 7–14 working days (may vary depending on laboratory workflow).

Why Choose Advanced BioCare Laboratories?

• Advanced molecular and cytogenetic diagnostics
• Experienced hematopathology specialists
• High-quality FISH and karyotyping analysis
• Accurate, reliable, and timely reports
• Trusted diagnostic support for oncology and hematology patients